APLT
insider transactionsApplied Therapeutics, Inc. — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
No open-market buys or sells this period. The trades below are grants, option exercises and gifts, which carry no market price.
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Other·U
Chief Commercial Officer
—
5.8K sh
-
Other·D
Chief Commercial Officer
—
862.5K sh
Own -99%
-
Other·U
Chief Operating Officer and C…
—
57.1K sh
-
Other·D
Chief Operating Officer and C…
—
1.0M sh
Own -95%
-
Other·D
Director
—
200.0K sh
Own -100%
-
Other·D
Director
—
16.5K sh
Own -100%
-
Other·D
Director
—
10.2K sh
Own -100%
-
Other·D
Director
—
20.5K sh
Own -100%
-
Other·U
Director
—
42.5K sh
-
Other·D
Director
—
22.5K sh
Own -35%
-
Other·D
Chief Financial Officer
—
40.5K sh
Own -100%
-
Other·D
Chief Financial Officer
—
150.0K sh
Own -100%
-
Other·D
Chief Financial Officer
—
16.5K sh
Own -100%
-
Other·D
Chief Financial Officer
—
10.2K sh
Own -100%
-
Other·D
Chief Financial Officer
—
20.5K sh
Own -100%
-
Other·U
Chief Financial Officer
—
153.0K sh
-
Other·D
Chief Financial Officer
—
2.4M sh
Own -94%
-
Other·D
Chief Medical Officer
—
4.9K sh
Own -100%
-
Other·D
Chief Medical Officer
—
19.5K sh
Own -100%
-
Other·U
Chief Medical Officer
—
60.9K sh
-
Other·D
Chief Medical Officer
—
1.2M sh
Own -95%
-
Other·D
Director
—
23.9K sh
Own -100%
-
Other·D
Director
—
200.0K sh
Own -100%
-
Other·D
Director
—
16.5K sh
Own -100%
-
Other·D
Director
—
10.2K sh
Own -100%
-
Other·D
Director
—
20.5K sh
Own -100%
-
Other·U
Director
—
82.9K sh
-
Other·D
Director
—
22.5K sh
Own -21%
-
Other·D
Director
—
200.0K sh
Own -100%
-
Other·D
Director
—
16.5K sh
Own -100%
-
Other·D
Director
—
10.2K sh
Own -100%
-
Other·D
Director
—
20.5K sh
Own -100%
-
Other·U
Director
—
42.5K sh
-
Other·D
Director
—
22.5K sh
Own -35%
-
Grant·A
Chief Financial Officer
$0
150.0K sh
Own +13%
-
Grant·A
Chief Commercial Officer
$0
312.5K sh
Own +56%
-
Grant·A
Chief Operating Officer and C…
$0
437.5K sh
Own +71%
-
Grant·A
Chief Financial Officer
$0
1.2M sh
Own +89%
-
Grant·A
Chief Medical Officer
$0
437.5K sh
Own +51%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Feb 3, 2026 | Corwin Dale Hooks | Other U | 5.8K | — |
| Feb 3, 2026 | Corwin Dale Hooks | Other D | 862.5K | — |
| Feb 3, 2026 | Constantine Chinoporos | Other U | 57.1K | — |
| Feb 3, 2026 | Constantine Chinoporos | Other D | 1.0M | — |
| Feb 3, 2026 | Jay S Skyler | Other D | 200.0K | — |
| Feb 3, 2026 | Jay S Skyler | Other D | 16.5K | — |
| Feb 3, 2026 | Jay S Skyler | Other D | 10.2K | — |
| Feb 3, 2026 | Jay S Skyler | Other D | 20.5K | — |
| Feb 3, 2026 | Jay S Skyler | Other U | 42.5K | — |
| Feb 3, 2026 | Jay S Skyler | Other D | 22.5K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other D | 40.5K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other D | 150.0K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other D | 16.5K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other D | 10.2K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other D | 20.5K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other U | 153.0K | — |
| Feb 3, 2026 | Leslie D. Funtleyder KEY | Other D | 2.4M | — |
| Feb 3, 2026 | Evan Prescott Bailey | Other D | 4.9K | — |
| Feb 3, 2026 | Evan Prescott Bailey | Other D | 19.5K | — |
| Feb 3, 2026 | Evan Prescott Bailey | Other U | 60.9K | — |
| Feb 3, 2026 | Evan Prescott Bailey | Other D | 1.2M | — |
| Feb 3, 2026 | Teena Lerner | Other D | 23.9K | — |
| Feb 3, 2026 | Teena Lerner | Other D | 200.0K | — |
| Feb 3, 2026 | Teena Lerner | Other D | 16.5K | — |
| Feb 3, 2026 | Teena Lerner | Other D | 10.2K | — |
| Feb 3, 2026 | Teena Lerner | Other D | 20.5K | — |
| Feb 3, 2026 | Teena Lerner | Other U | 82.9K | — |
| Feb 3, 2026 | Teena Lerner | Other D | 22.5K | — |
| Feb 3, 2026 | Stacy J. Kanter | Other D | 200.0K | — |
| Feb 3, 2026 | Stacy J. Kanter | Other D | 16.5K | — |
| Feb 3, 2026 | Stacy J. Kanter | Other D | 10.2K | — |
| Feb 3, 2026 | Stacy J. Kanter | Other D | 20.5K | — |
| Feb 3, 2026 | Stacy J. Kanter | Other U | 42.5K | — |
| Feb 3, 2026 | Stacy J. Kanter | Other D | 22.5K | — |
| Jan 1, 2026 | Leslie D. Funtleyder KEY | Grant A | 150.0K | $0 |
| Dec 19, 2025 | Corwin Dale Hooks | Grant A | 312.5K | $0 |
| Dec 19, 2025 | Constantine Chinoporos | Grant A | 437.5K | $0 |
| Dec 19, 2025 | Leslie D. Funtleyder KEY | Grant A | 1.2M | $0 |
| Dec 19, 2025 | Evan Prescott Bailey | Grant A | 437.5K | $0 |
About APLT insider trading
This page tracks insider transactions for Applied Therapeutics, Inc. (APLT) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.